Skip to content

Avitene 1010010Recalls & reported problems

Davol Inc. · Avitene Flour, 0.5 gram · Class 3 · Implant

Data updated Oct 13, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00801741010439), received between Dec 15, 2022 and Dec 15, 2022 — classified as 1 injury.

The most frequently reported specific device problem is “Patient-Device Incompatibility” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Most reported problems

Device problems

  • Patient-Device Incompatibility1

Patient problems

  • Pain1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryDec 15, 2022Patient-Device Incompatibility; Patient-Device Incompatibility

    AS REPORTED, DURING A PERCUTANEOUS LIVER BIOPSY PROCEDURE, BARD/DAVOL AVITENE FLOUR HEMOSTAT WAS USED TO STOP BLEEDING. AS REPORTED, THE PATIENT EXPERIENCED PAIN FOR ONE HOUR POST APPLICATION OF AVITENE AND REQUIRED ANALGESICS TO TREAT THE PAIN.

    Patient problems: Pain

    MAUDE report 15988426 ↗

Other Agent, absorbable hemostatic, collagen based devices

All Agent, absorbable hemostatic, collagen based devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page